Esophageal Cancer Clinical Trial

Routine Post-Operative Supplemental Nutrition

Summary

Patients undergoing an esophagectomy will be randomized to receive either (1) routine post-operative tube feeding for 1 month post-operative or (2) usual practice, which is tube feeding to continue in the hospital until the patient is taking adequate nutrition by mouth at POD#8, or upon discharge.

Specific Aim 1 is to determine the occurrence of common complications and readmissions post-operatively between the two patient groups. The investigators hypothesize that routine use of tube feeding may reduce the occurrence of post-operative complications.

Specific Aim 2 is to determine if routine dietary supplementation with enteral tube affects recovery and QOL after esophagectomy. The investigators hypothesize that routine post-operative supplementation will enhance patients recovery and QOL.

For esophagectomy specifically, there is very limited literature evaluating the complication rate and QOL associated with the length of post-operative tube feeding and adequate nutritional requirements. Small randomized studies have not shown a benefit to routine tube feeding, although the numbers were very small, ranging from 12-70 per group. The investigators will randomize 200 patients for the purpose of this study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients undergoing an elective esophagectomy
Jejunal feeding tube placed at the time of surgery

Exclusion Criteria:

Emergent esophagectomy procedure
Inability to provide informed consent or to complete testing or data collection
Unwillingness to be randomized
Tube feeding dependent on discharge

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

30

Study ID:

NCT02297607

Recruitment Status:

Terminated

Sponsor:

University of Michigan

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Michigan Health System
Ann Arbor Michigan, 48109, United States

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

30

Study ID:

NCT02297607

Recruitment Status:

Terminated

Sponsor:


University of Michigan

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider